IFM2009-02-Pomalidomide and Dexamethasone Phase 2 Myeloma

NCT01053949 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

84

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Pomalidomide
DRUG: Pomalidomide

Sponsor

University Hospital, Lille

Collaborators

[object Object]